Post-approval studies (Phase 4)Study completedNCT05223335What this trial is testingClopidogrel Monotherapy in Patients With High Bleeding RiskWho this might be right forBleeding Complications Mayo Clinic 98
Not applicableActive Not RecruitingNCT05457582What this trial is testingPCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCIWho this might be right forAcute Coronary SyndromeHyperlipidemiasPercutaneous Coronary Intervention+1 more Nanjing First Hospital, Nanjing Medical University 1,212
Post-approval studies (Phase 4)Looking for participantsNCT04499859What this trial is testingLow Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMIWho this might be right forMyocardial InfarctionStatin Adverse ReactionHMG-CoA Reductase Inhibitor Toxicity Kiyuk Chang, MD,PhD 3,548
Post-approval studies (Phase 4)Looking for participantsNCT04899479What this trial is testingPeri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary InterventionWho this might be right forAcute Myocardial InfarctionHeart Failure Samsung Medical Center 200
Post-approval studies (Phase 4)Study completedNCT05130892What this trial is testingEffect of Inflammasome Inhibitor on hsCRP in Patients After PCIWho this might be right forNLRP3hsCRPPercutaneous Coronary Intervention Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 132